C

Circio Holding
CRNA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NOK62.04M
EV
NOK61.07M
Shares Outstanding
105.51M
Beta
1.53

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
NOK1.00
P/E 2025E
0.94x
P/Revenue 2025E
0.63x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Circio Holding ASA

gainify

C

Circio Holding ASA

CRNA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; a...

Sector

Industry

CEO

Wiklund, Erik

Employees

9

IPO Date

Headquarters

Universitetsgata 2, Oslo, Oslo, 0164, Norway

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.